Altered expression of IκBα in prostate cancer specimens has been linked to constitutive NF-κB activation through phosphorylation of IκBα at Ser32/36, resulting in the release and nuclear translocation of NF-κB [17–20]. This evidence concerns the gene NFKB1 and prostate carcinoma.